miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis

Figure 3

miR-20b inhibits T cell activation. (a) Flow cytometric analysis of CD25 and (b) CD69 expression in Jurkat cells transfected with either miR-20b or anti-miR-20b or their respective controls (miR-NC or anti-miR-NC). (c) Expression levels of IL-2 and (d) IL-10 as determined by qRT-PCR in Jurkat cells transfected with either miR-20b or anti-miR-20b or their respective controls (miR-NC or anti-miR-NC). .

(a)

(b)

(c)

(d)